Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
October 15, 2024
Characterization of six clinical drugs and dietary intervention in the nonobese CDAA-HFD mouse model of MASH and progressive fibrosis
Malte Hasle Nielsen, Jacob Nøhr-Meldgaard, Mathias Bonde Møllerhøj, et al.
Ebiomedicine
|
January 17, 2026
Generation and characterisation of a humanised GLP-1 receptor mouse model for translational drug development
Nina Sonne, Micaela Roque, Line Fisker Zachariassen, et al.
Physiological Reports
|
October 11, 2024
Reproducible lung protective effects of a TGFβR1/ALK5 inhibitor in a bleomycin-induced and spirometry-confirmed model of IPF in male mice
Asbjørn Graver Petersen, Stefanie H Korntner, Jamal Bousamaki, et al.
Hepatology Communications
|
July 7, 2020
Activation of Adenosine Monophosphate-Activated Protein Kinase Reduces the Onset of Diet-Induced Hepatocellular Carcinoma in Mice
Dieter Schmoll, Nicole Ziegler, Benoit Viollet, et al.
World Journal of Gastroenterology
|
September 24, 2019
Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source
Michelle L Boland, Denise Oró, Kirstine S Tølbøl, et al.
British Journal of Pharmacology
|
June 9, 2024
Paraoxonase-2 agonist vutiglabridin promotes autophagy activation and mitochondrial function to alleviate non-alcoholic steatohepatitis
Gu-Choul Shin, Hyeong Min Lee, Nayeon Kim, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
April 13, 2026
Therapeutic Efficacy, Biomarker Signatures and Translatability of Semaglutide in the Liver Biopsy-Confirmed GAN DIO-MASH Mouse Model
Jens Bjelke Kristensen, Jacob Nøhr-Meldgaard, Susanne E Pors, et al.
Nature Metabolism
|
June 2, 2020
Resolution of NASH and hepatic fibrosis by the GLP-1R/GcgR dual-agonist Cotadutide via modulating mitochondrial function and lipogenesis
Michelle L Boland, Rhianna C Laker, Karly Mather, et al.
Hepatology Communications
|
November 25, 2024
Aberrant basement membrane production by HSCs in MASLD is attenuated by the bile acid analog INT-767
Prakash Ramachandran, Madara Brice, Elena F Sutherland, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 26, 2020
Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative
Geurt Stokman, Anita M van den Hoek, Ditte Denker Thorbekk, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
October 15, 2024
Characterization of six clinical drugs and dietary intervention in the nonobese CDAA-HFD mouse model of MASH and progressive fibrosis
Malte Hasle Nielsen, Jacob Nøhr-Meldgaard, Mathias Bonde Møllerhøj, et al.
Ebiomedicine
|
January 17, 2026
Generation and characterisation of a humanised GLP-1 receptor mouse model for translational drug development
Nina Sonne, Micaela Roque, Line Fisker Zachariassen, et al.
Physiological Reports
|
October 11, 2024
Reproducible lung protective effects of a TGFβR1/ALK5 inhibitor in a bleomycin-induced and spirometry-confirmed model of IPF in male mice
Asbjørn Graver Petersen, Stefanie H Korntner, Jamal Bousamaki, et al.
Hepatology Communications
|
July 7, 2020
Activation of Adenosine Monophosphate-Activated Protein Kinase Reduces the Onset of Diet-Induced Hepatocellular Carcinoma in Mice
Dieter Schmoll, Nicole Ziegler, Benoit Viollet, et al.
World Journal of Gastroenterology
|
September 24, 2019
Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source
Michelle L Boland, Denise Oró, Kirstine S Tølbøl, et al.
British Journal of Pharmacology
|
June 9, 2024
Paraoxonase-2 agonist vutiglabridin promotes autophagy activation and mitochondrial function to alleviate non-alcoholic steatohepatitis
Gu-Choul Shin, Hyeong Min Lee, Nayeon Kim, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
April 13, 2026
Therapeutic Efficacy, Biomarker Signatures and Translatability of Semaglutide in the Liver Biopsy-Confirmed GAN DIO-MASH Mouse Model
Jens Bjelke Kristensen, Jacob Nøhr-Meldgaard, Susanne E Pors, et al.
Nature Metabolism
|
June 2, 2020
Resolution of NASH and hepatic fibrosis by the GLP-1R/GcgR dual-agonist Cotadutide via modulating mitochondrial function and lipogenesis
Michelle L Boland, Rhianna C Laker, Karly Mather, et al.
Hepatology Communications
|
November 25, 2024
Aberrant basement membrane production by HSCs in MASLD is attenuated by the bile acid analog INT-767
Prakash Ramachandran, Madara Brice, Elena F Sutherland, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 26, 2020
Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative
Geurt Stokman, Anita M van den Hoek, Ditte Denker Thorbekk, et al.
Page
of 5